NM_006610.4:c.359A>G

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP3BP4_StrongBS1_SupportingBS2

The NM_006610.4(MASP2):​c.359A>G​(p.Asp120Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0265 in 1,613,734 control chromosomes in the GnomAD database, including 701 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.022 ( 51 hom., cov: 33)
Exomes 𝑓: 0.027 ( 650 hom. )

Consequence

MASP2
NM_006610.4 missense

Scores

10
3
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:4U:2B:3

Conservation

PhyloP100: 7.73

Publications

66 publications found
Variant links:
Genes affected
MASP2 (HGNC:6902): (MBL associated serine protease 2) This gene encodes a member of the peptidase S1 family of serine proteases. The encoded preproprotein is proteolytically processed to generate A and B chains that heterodimerize to form the mature protease. This protease cleaves complement components C2 and C4 in order to generate C3 convertase in the lectin pathway of the complement system. The encoded protease also plays a role in the coagulation cascade through cleavage of prothrombin to form thrombin. Myocardial infarction and acute stroke patients exhibit reduced serum concentrations of the encoded protein. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed. [provided by RefSeq, Feb 2016]
MASP2 Gene-Disease associations (from GenCC):
  • immunodeficiency due to MASP-2 deficiency
    Inheritance: AR Classification: STRONG Submitted by: Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 10: AlphaMissense, BayesDel_noAF, Cadd, Eigen, FATHMM_MKL, MutationAssessor, phyloP100way_vertebrate, PROVEAN, REVEL, REVEL [when BayesDel_addAF, max_spliceai, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.010086238).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0221 (3368/152328) while in subpopulation NFE AF = 0.0324 (2204/68018). AF 95% confidence interval is 0.0313. There are 51 homozygotes in GnomAd4. There are 1693 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAd4 at 51 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006610.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MASP2
NM_006610.4
MANE Select
c.359A>Gp.Asp120Gly
missense
Exon 3 of 11NP_006601.2
MASP2
NM_139208.3
c.359A>Gp.Asp120Gly
missense
Exon 3 of 5NP_631947.1O00187-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MASP2
ENST00000400897.8
TSL:1 MANE Select
c.359A>Gp.Asp120Gly
missense
Exon 3 of 11ENSP00000383690.3O00187-1
MASP2
ENST00000400898.3
TSL:1
c.359A>Gp.Asp120Gly
missense
Exon 3 of 5ENSP00000383691.3O00187-2
MASP2
ENST00000480221.1
TSL:1
n.379A>G
non_coding_transcript_exon
Exon 3 of 3

Frequencies

GnomAD3 genomes
AF:
0.0221
AC:
3370
AN:
152210
Hom.:
51
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00543
Gnomad AMI
AF:
0.0164
Gnomad AMR
AF:
0.0205
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00331
Gnomad FIN
AF:
0.0505
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0324
Gnomad OTH
AF:
0.0210
GnomAD2 exomes
AF:
0.0214
AC:
5366
AN:
250710
AF XY:
0.0212
show subpopulations
Gnomad AFR exome
AF:
0.00438
Gnomad AMR exome
AF:
0.0103
Gnomad ASJ exome
AF:
0.00328
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0471
Gnomad NFE exome
AF:
0.0323
Gnomad OTH exome
AF:
0.0181
GnomAD4 exome
AF:
0.0270
AC:
39418
AN:
1461406
Hom.:
650
Cov.:
32
AF XY:
0.0264
AC XY:
19204
AN XY:
726988
show subpopulations
African (AFR)
AF:
0.00364
AC:
122
AN:
33480
American (AMR)
AF:
0.0106
AC:
475
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00360
AC:
94
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00423
AC:
365
AN:
86250
European-Finnish (FIN)
AF:
0.0463
AC:
2453
AN:
52998
Middle Eastern (MID)
AF:
0.00329
AC:
19
AN:
5768
European-Non Finnish (NFE)
AF:
0.0310
AC:
34458
AN:
1111964
Other (OTH)
AF:
0.0237
AC:
1432
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
2352
4704
7056
9408
11760
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1216
2432
3648
4864
6080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0221
AC:
3368
AN:
152328
Hom.:
51
Cov.:
33
AF XY:
0.0227
AC XY:
1693
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.00541
AC:
225
AN:
41588
American (AMR)
AF:
0.0205
AC:
314
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00311
AC:
15
AN:
4830
European-Finnish (FIN)
AF:
0.0505
AC:
536
AN:
10618
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0324
AC:
2204
AN:
68018
Other (OTH)
AF:
0.0208
AC:
44
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
184
368
553
737
921
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0285
Hom.:
138
Bravo
AF:
0.0189
TwinsUK
AF:
0.0186
AC:
69
ALSPAC
AF:
0.0257
AC:
99
ESP6500AA
AF:
0.00590
AC:
26
ESP6500EA
AF:
0.0288
AC:
248
ExAC
AF:
0.0222
AC:
2692
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.0265
EpiControl
AF:
0.0268

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
3
2
-
Immunodeficiency due to MASP-2 deficiency (5)
-
-
2
not specified (2)
-
-
1
MASP2-related disorder (1)
1
-
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.82
BayesDel_addAF
Benign
-0.035
T
BayesDel_noAF
Pathogenic
0.20
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.22
T
Eigen
Pathogenic
0.80
Eigen_PC
Pathogenic
0.71
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.91
D
MetaRNN
Benign
0.010
T
MetaSVM
Benign
-0.38
T
MutationAssessor
Pathogenic
3.6
H
PhyloP100
7.7
PrimateAI
Uncertain
0.55
T
PROVEAN
Pathogenic
-6.6
D
REVEL
Pathogenic
0.76
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.98
D
Vest4
0.32
MPC
0.29
ClinPred
0.052
T
GERP RS
4.8
Varity_R
0.95
gMVP
0.87
Mutation Taster
=44/56
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72550870; hg19: chr1-11106666; COSMIC: COSV68896437; COSMIC: COSV68896437; API